Sarissa Capital Acquisition Corp. (SRSA) Stock Analysis

What Sarissa Capital Acquisition Corp. does

Sarissa Capital Acquisition Corp. currently possesses no principal operations. Its core mission revolves around completing a strategic business combination, which may involve a merger, share or asset acquisition, reorganization, or a similar transaction with another enterprise. The company specifically aims to identify and acquire a business focused within the healthcare and biopharmaceutical sectors. Founded in 2020, it is headquartered in Greenwich, Connecticut.

Key metrics

ETFs linked to SRSA

Broad-market and Financial Services sector ETFs an investor holding Sarissa Capital Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SRSA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Sarissa Capital Acquisition Corp.?

Sarissa Capital Acquisition Corp. trades under the ticker SRSA on NASDAQ.

Which exchange is SRSA listed on?

SRSA is listed on NASDAQ.

What sector does Sarissa Capital Acquisition Corp. operate in?

Sarissa Capital Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze SRSA in a portfolio?

PortView shows SRSA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.